Drug
Trastuzumab
Data on this page refer exclusively to patients treated with
Trastuzumab combined with SBRT, without concurrent use of
drugs from other classes.
Combination therapy data and pooled group-level evidence are available on the
anti-HER2 mAb group page.
Drug Profile
| Therapeutic Class | Monoclonal Antibodies (mAbs) |
| Drug Class | HER2-Targeting |
| Group | anti-HER2 mAb |
| Mechanism of Action | Anti-HER2 antibody |
| Half-life | 13-27 d |
Location
Treated site
